Gilead Sciences, Inc. (GILD) Earnings History
Net Loss36 years of earnings data (1990–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Gilead Sciences, Inc. (GILD) Earnings Overview
As of October 23, 2026, Gilead Sciences, Inc. (GILD) reported trailing twelve-month net income of -$3.24B, reflecting +1684.2% year-over-year growth. The company earned $-2.61 per diluted share over the past four quarters, with a net profit margin of 28.9%.
Looking at the long-term picture, GILD's 5-year EPS compound annual growth rate (CAGR) stands at +133.6%, indicating exceptional earnings growth. The company achieved its highest annual net income of $18.11B in fiscal 2015.
Gilead Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ABBV ($6.31B net income, 6.9% margin), BMY ($9.28B net income, 14.6% margin), AMGN ($8.74B net income, 21.0% margin), GILD has outperformed on profitability metrics. Compare GILD vs ABBV →
GILD Earnings vs Peers
Earnings metrics vs comparable public companies
GILD Historical Earnings Data (1990–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $8.51B | +1672.9% | $11.70B | $6.78 | 28.9% | 39.7% |
| 2024 | $480M | -91.5% | $1.66B | $0.38 | 1.7% | 5.8% |
| 2023 | $5.67B | +23.4% | $7.61B | $4.50 | 20.9% | 28.0% |
| 2022 | $4.59B | -26.2% | $7.33B | $3.64 | 16.8% | 26.9% |
| 2021 | $6.22B | +4961.0% | $9.92B | $4.93 | 22.8% | 36.3% |
| 2020 | $123M | -97.7% | $4.07B | $0.10 | 0.5% | 16.5% |
| 2019 | $5.39B | -1.3% | $4.29B | $4.22 | 24.0% | 19.1% |
| 2018 | $5.46B | +17.9% | $8.20B | $4.17 | 24.7% | 37.1% |
| 2017 | $4.63B | -65.7% | $14.12B | $3.51 | 17.7% | 54.1% |
| 2016 | $13.50B | -25.4% | $17.63B | $9.94 | 44.4% | 58.0% |
| 2015 | $18.11B | +49.6% | $22.19B | $11.91 | 55.5% | 68.0% |
| 2014 | $12.10B | +293.5% | $15.27B | $7.35 | 48.6% | 61.3% |
| 2013 | $3.08B | +18.6% | $4.52B | $1.81 | 27.5% | 40.4% |
| 2012 | $2.59B | -7.5% | $4.01B | $1.64 | 26.7% | 41.3% |
| 2011 | $2.80B | -3.4% | $3.79B | $1.78 | 33.4% | 45.2% |
| 2010 | $2.90B | +10.1% | $3.96B | $1.66 | 36.5% | 49.8% |
| 2009 | $2.64B | +33.2% | $3.53B | $1.41 | 37.6% | 50.3% |
| 2008 | $1.98B | +22.5% | $2.68B | $1.05 | 37.1% | 50.2% |
| 2007 | $1.62B | +235.7% | $2.16B | $0.84 | 38.2% | 51.2% |
| 2006 | -$1.19B | -246.2% | -$759M | $-0.65 | -39.3% | -25.1% |
| 2005 | $814M | +81.1% | $1.11B | $0.43 | 40.1% | 54.7% |
| 2004 | $449M | +724.1% | $627M | $0.25 | 33.9% | 47.4% |
| 2003 | -$72M | -199.9% | -$159M | $-0.04 | -8.3% | -18.3% |
| 2002 | $72M | +37.9% | $81M | $0.04 | 15.4% | 17.4% |
| 2001 | $52M | +192.1% | -$121M | $0.03 | 22.4% | -51.6% |
| 2000 | -$57M | +14.6% | -$52M | $-0.04 | -29.0% | -26.8% |
| 1999 | -$67M | -48.4% | -$52M | $-0.05 | -39.3% | -30.6% |
| 1998 | -$45M | +38.5% | -$78M | $-0.04 | -29.6% | -51.8% |
| 1997 | -$73M | -235.9% | -$72M | $-0.03 | -55.1% | -54.5% |
| 1996 | -$22M | +20.8% | -$36M | $-0.02 | -65.0% | -108.1% |
| 1995 | -$27M | +12.5% | -$32M | $-0.04 | -1014.8% | -1185.2% |
| 1994 | -$31M | -122.0% | -$35M | $-0.04 | -638.8% | -718.4% |
| 1992 | -$14M | -213.3% | -$18M | $-0.03 | -335.7% | -433.3% |
| 1991 | -$5M | -12.5% | -$6M | $-0.01 | -160.7% | -225.0% |
| 1990 | -$4M | - | -$5M | $-0.01 | -307.7% | -369.2% |
Download Data
Export GILD earnings history in CSV or JSON format
Free sign-in required to download data
GILD Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
GILD Stock Analysis
Bull/bear thesis, analyst target revisions, and earnings execution.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
36+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GILD — Frequently Asked Questions
Quick answers to the most common questions about buying GILD stock.
What is GILD earnings per share (EPS)?
GILD trailing twelve-month (TTM) diluted EPS is $-2.61, reflecting +1684.2% year-over-year growth. The 5-year EPS CAGR is +133.6%. Complete EPS history from 1990 to 2025 is available in the table on this page.
What is Gilead Sciences, Inc.'s net income?
Gilead Sciences, Inc. (GILD) trailing twelve-month net income is $-3.2B as of 2025. Earnings grew +1684.2% year-over-year. Gilead Sciences, Inc. has been profitable for 19 consecutive years.
Is GILD profitable?
GILD is not currently profitable on a TTM basis, reporting a net loss of $-3.2B. Net margin is +28.9%. Investors should monitor for a return to profitability.
What is GILD's earnings growth rate?
GILD compound annual EPS growth rates (CAGR): 1-Year: +1684.2%, 3-Year: +23.0%, 5-Year: +133.6%, 10-Year: -5.5%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1990 to 2025.
What are GILD's profit margins?
Gilead Sciences, Inc. net profit margin is +28.9%, operating margin is +39.7%, and gross margin is +78.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +40.7%.
Is GILD growing earnings?
Yes, GILD earnings are accelerating — EPS growth of +1684.2% exceeds the 5-year CAGR of +133.6%. TTM net income reached $-3.2B. Earnings momentum is strengthening.
What was GILD's best earnings year?
Gilead Sciences, Inc.'s highest annual net income on record is $18.1B, achieved in fiscal year 2015. Earnings history on this page spans 1990 to 2025 and includes all annual and quarterly figures.
What were GILD's earnings last quarter?
GILD's most recent reported quarter was Q2 2026. Net income was $-10.5B with diluted EPS of $-8.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.